Prolanta and all the patents was the reason I invested here. A lot of potential if the 2nd cohort results were positive for phase 1. Unfortunately the 2 people tested had slight reactions to the injections.
Prolanta has to be reformulated at this point for a possible different delivery method. The only hope Oncolix has would be a huge investor willing to invest a ton of cash.
Who knows maybe GHS would fund this, especially being the largest shareholder.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.